Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Lobbying Update: $80,000 of ASTRAZENECA lobbying was just disclosed

None

$80,000 of ASTRAZENECA lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues related to Medicare Part D and Part B Pricing Reform; Issues related to the Medicaid Pricing reform; Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act. Issues related to the 340B Program - Public Health Service Act (PL 78-410)."

You can find more data on corporate lobbying on Quiver Quantitative.

AZN Congressional Stock Trading

Members of Congress have traded $AZN stock 7 times in the past 6 months. Of those trades, 5 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $AZN stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

AZN Hedge Fund Activity

We have seen 572 institutional investors add shares of AZN stock to their portfolio, and 714 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

AZN Analyst Ratings

Wall Street analysts have issued reports on $AZN in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Jefferies issued a "Buy" rating on 10/27/2025

To track analyst ratings and price targets for AZN, check out Quiver Quantitative's $AZN forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles